These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24482352)

  • 1. Intravenous drug delivery in neonates: lessons learnt.
    Sherwin CM; Medlicott NJ; Reith DM; Broadbent RS
    Arch Dis Child; 2014 Jun; 99(6):590-4. PubMed ID: 24482352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed delivery of intravenous gentamicin in neonates: impact of infusion variables.
    Medlicott NJ; Reith DM; McCaffrey F; Krittaphol W; Broadbent RS
    J Pharm Pharmacol; 2013 Mar; 65(3):370-8. PubMed ID: 23356846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A literature review on flow-rate variability in neonatal IV therapy.
    van der Eijk AC; van Rens RM; Dankelman J; Smit BJ
    Paediatr Anaesth; 2013 Jan; 23(1):9-21. PubMed ID: 23057436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancies between predicted and observed rates of intravenous gentamicin delivery for neonates.
    Sherwin CM; McCaffrey F; Broadbent RS; Reith DM; Medlicott NJ
    J Pharm Pharmacol; 2009 Apr; 61(4):465-71. PubMed ID: 19298693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal intravenous therapy.
    Duck S
    J Intraven Nurs; 1997; 20(3):121-8. PubMed ID: 9214923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The delivery of drugs to patients by continuous intravenous infusion: modeling predicts potential dose fluctuations depending on flow rates and infusion system dead volume.
    Lovich MA; Kinnealley ME; Sims NM; Peterfreund RA
    Anesth Analg; 2006 Apr; 102(4):1147-53. PubMed ID: 16551914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous infusion conditions. Implications for pharmacokinetic monitoring.
    Nahata MC
    Clin Pharmacokinet; 1993 Mar; 24(3):221-9. PubMed ID: 8462228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro measurement of flow rate variability in neonatal IV therapy with and without the use of check valves.
    van der Eijk AC; van der Plas AJ; van der Palen CJ; Dankelman J; Smit BJ
    J Neonatal Perinatal Med; 2014; 7(1):55-64. PubMed ID: 24815706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer control of drug delivery by continuous intravenous infusion: bridging the gap between intended and actual drug delivery.
    Parker MJ; Lovich MA; Tsao AC; Wei AE; Wakim MG; Maslov MY; Tsukada H; Peterfreund RA
    Anesthesiology; 2015 Mar; 122(3):647-58. PubMed ID: 25419684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of inline filtration on delivery of gentamicin at various flow rates.
    Satoh Y; Isohata E; Iwata S; Akita H; Oikawa T; Sunakawa K; Kurita Y; Machida H; Takizawa K
    Keio J Med; 1992 Mar; 41(1):16-20. PubMed ID: 1583814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous insulin infusions in neonates: pharmacologic availability of insulin in intravenous solutions.
    Simeon PS; Geffner ME; Levin SR; Lindsey AM
    J Pediatr; 1994 May; 124(5 Pt 1):818-20. PubMed ID: 8176576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimization of the preanalytical error in pharmacokinetic analyses and therapeutic drug monitoring: focus on IV drug administration.
    Kontny NE; Boos J; Würthwein G; Hempel G; Boddy AV; Groll AH; Krischke M
    Ther Drug Monit; 2012 Aug; 34(4):460-6. PubMed ID: 22660605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of drug delivery disturbances during continuous intravenous infusion: an in vitro study on a new multi-lumen infusion access device.
    Foinard A; Décaudin B; Barthélémy C; Debaene B; Odou P
    Ann Fr Anesth Reanim; 2013 Sep; 32(9):e107-12. PubMed ID: 23958179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication and volume delivery by gravity-driven micro-drip intravenous infusion: potential variations during "wide-open" flow.
    Pierce ET; Kumar V; Zheng H; Peterfreund RA
    Anesth Analg; 2013 Mar; 116(3):614-8. PubMed ID: 23400996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical parameters in drug delivery by intravenous infusion.
    Peterfreund RA; Philip JH
    Expert Opin Drug Deliv; 2013 Aug; 10(8):1095-108. PubMed ID: 23565777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Impact of Infusion Technique on Drug Delivery.
    Simon N; Vasseur M; Guillaussier A; Legrand JF; Lebecque M; Barthélémy C; Décaudin B; Odou P
    Ther Drug Monit; 2016 Apr; 38(2):268-73. PubMed ID: 26452242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of carrier flow rate and infusion set dead-volume on the dynamics of intravenous drug delivery.
    Lovich MA; Doles J; Peterfreund RA
    Anesth Analg; 2005 Apr; 100(4):1048-1055. PubMed ID: 15781520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of drug delivery dynamics via a pediatric central venous infusion system: quantification of delays in achieving intended doses.
    Bartels K; Moss DR; Peterfreund RA
    Anesth Analg; 2009 Oct; 109(4):1156-61. PubMed ID: 19762743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infusion set characteristics such as antireflux valve and dead-space volume affect drug delivery: an experimental study designed to enhance infusion sets.
    Lannoy D; Décaudin B; Dewulf S; Simon N; Secq A; Barthélémy C; Debaene B; Odou P
    Anesth Analg; 2010 Dec; 111(6):1427-31. PubMed ID: 21106966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic monitoring as an aid in rationalizing aminoglycoside dosage techniques in the neonate.
    Spruyt LL; Kirsten GF; Parkin DP; Müller GJ; Kriegler A
    S Afr Med J; 1987 Oct; 72(7):463-5. PubMed ID: 3660149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.